17Aug
UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By:
Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-82301/
Related
Associates’ voices matter in hiring decisions—at some firms more than others, but at all firms, at...
Read More >
The first year of Governor Gavin Newsom’s term produced many significant pieces of employment legis...
Read More >
On April 27, 2020, and as part of its response to the COVID-19 pandemic, the Bureau issued a stateme...
Read More >
January 1, 2020, organizations that employ individuals based in Illinois will need to keep in mind t...
Read More >
The US Supreme Court ruled on January 27 that the administration can begin to implement the public c...
Read More >
In celebration of the 100th episode of Corruption Crime and Compliance, Tom Fox, the Compliance Evan...
Read More >